Clinical trials recruiting in Levallois-Perret, France

Phase breakdown

Conditions recruiting in Levallois-Perret, France

Recruiting trials in Levallois-Perret, France

• A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer
  NCT05639413 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.
  NCT05689151 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Combination of Spartalizumab, mDCF and Radiotherapy in Patients With Metastatic Squamous Cell Anal Carcinoma
  NCT04894370 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• DESTINY Breast Respond HER2-(Ultra)Low Europe
  NCT05945732 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Erectile Dysfunction in Good Prognosis Prostate Cancer : Comparison Between Brachytherapy and Stereotactic Body Radiotherapy
  NCT03830788 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male
• ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
  NCT05059444 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• PRostate Olaparib Real World Evidence Study
  NCT06031805 · Phase: Not specified · Ages: 18 Years and older · Sex: Male
• Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage TNBC
  NCT06078384 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Phase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamide in Patients With Metastatic Hormone-sensitive Prostate Cancer Who Did Not Achieve a Deep PSA Response After Initial Treatment With Apalutamide: REINFORCE Trial.
  NCT07333066 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male
• Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
  NCT06393374 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Levallois-Perret, France?

10 recruiting trials have at least one study site in Levallois-Perret, France.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.